Ignite Creation Date:
2025-12-24 @ 6:34 PM
Ignite Modification Date:
2026-01-01 @ 10:23 PM
Study NCT ID:
NCT04334057
Status:
COMPLETED
Last Update Posted:
2025-08-29
First Post:
2020-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-31
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-02
First Submit QC Date:
None
Study First Post Date:
2020-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-28
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED